Physician

David Brown, M.D.

According to 2025 Medicare claims, David Brown, M.D. (NPI: 1548368509) practices ophthalmology in the Houston-Pasadena-The Woodlands, TX market, with the plurality of this provider's patient population coming from Harris, TX. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF HOUSTON PLLC (NPI: 1902975352; TIN: 742109903) and primary practice location at 77429-4699. Brown is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542), participating under the MSSP model.

Brown's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 964 traditional Medicare patients, billed 37,989 HCPCS/CPT codes, and received $5,871,583 in Medicare payments. The top billing code was J3590 (Unclassified biologics). Part D data shows 289 prescription claims across 100 beneficiaries totaling $11,690 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 916 records totaling $11,852,874. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $36,002 to $11,690. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,137	16,934	$4,159,293
2016	1,234	19,615	$4,954,974
2017	1,183	19,211	$4,705,868
2018	1,228	23,209	$5,235,265
2019	1,348	26,372	$5,856,845
2020	1,255	24,114	$5,414,712
2021	1,231	23,528	$5,286,865
2022	1,158	17,140	$4,671,468
2023	1,039	19,980	$5,772,264
2024	964	37,989	$5,871,583

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	149	494	$36,002
2016	130	436	$30,699
2017	113	376	$27,877
2018	136	418	$33,102
2019	152	494	$34,113
2020	138	454	$43,331
2021	127	379	$32,147
2022	106	344	$22,789
2023	101	256	$17,325
2024	100	289	$11,690

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J3590	Unclassified biologics	151	311	$2,114
J0177	Injection, aflibercept hd, 1 mg	159	7,160	$263
67028	Injection of drug into eye	392	1,934	$113
92014	Established patient complete exam of visual system	816	1,288	$94
92134	Imaging of retina	895	2,639	$32

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	66	2,452	$3,064
Bromfenac Sodium	Bromfenac Sodium	13	383	$2,349
Ketorolac Tromethamine	Ketorolac Tromethamine	60	2,988	$1,301
Atropine Sulfate	Atropine Sulfate	14	440	$407
Moxifloxacin	Moxifloxacin Hcl	14	196	$306

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	88	$52,326	Celltrion, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	828	$11,800,548	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Brown, M.D.?

Tedicare shows public-source Medicare data for David Brown, M.D. (NPI 1548368509), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Brown, M.D. have ACO affiliation data?

David Brown, M.D. is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542).

What billing organization is linked to David Brown, M.D.?

David Brown, M.D. is linked to RETINA CONSULTANTS OF HOUSTON PLLC (billing NPI 1902975352) in the available physician profile data.

Does David Brown, M.D. have Open Payments data?

David Brown, M.D. has 916 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.